FACNX
Price
$89.55
Change
+$0.11 (+0.12%)
Updated
Aug 20 closing price
Net Assets
1.16B
FTCNX
Price
$89.08
Change
+$0.11 (+0.12%)
Updated
Aug 20 closing price
Net Assets
1.16B
Interact to see
Advertisement

FACNX vs FTCNX

FACNX vs FTCNX Comparison Chart in %
View a ticker or compare two or three
VS
FACNX vs. FTCNX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FACNX is a StrongBuy and FTCNX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FACNX (1.16B) and FTCNX (1.16B) have equal amount of cash in the bank . FACNX pays higher dividends than FTCNX: FACNX (0.44) vs FTCNX (0.18). FACNX was incepted earlier than FTCNX: FACNX (19 years) vs FTCNX (19 years). FTCNX (1.38) is less costly to investors than FACNX (1.13). FACNX (17.00) and FTCNX (17.00) have comparable annual turnover. FACNX initial investment is less costly to investors than FTCNX (4%) vs FTCNX (4%). FACNX (0) and FTCNX (0) have matching initial minimum investment requirements. FACNX (18.93) and FTCNX (18.63) have marching annual gain over last year. FACNX (48.55) and FTCNX (46.56) have equivalent 5 years return.
FACNXFTCNXFACNX / FTCNX
Total Expense Ratio1.131.3882%
Annual Report Gross Expense Ratio1.131.3882%
Fund Existence19 years19 years-
Gain YTD14.97014.779101%
Front Load6%4%164%
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.16B1.16B100%
Annual Yield % from dividends0.440.18246%
Returns for 1 year18.9318.63102%
Returns for 3 years51.7650.56102%
Returns for 5 years48.5546.56104%
Returns for 10 years89.8787.27103%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JGASX42.440.19
+0.45%
JPMorgan Growth Advantage I
TSPRX5.330.02
+0.38%
Transamerica Small Cap Growth R
FCUIX20.990.08
+0.38%
NYLI PineStone U.S. Equity Class I
SMDRX22.920.07
+0.31%
Hartford Schroders US MidCap Opps SDR
FHCCX43.67N/A
N/A
Fidelity Advisor Health Care C